my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company's award-winning TRIC techno more
Multidrug-resistant bacterial infections that cannot be treated by any known antibiotics pose a serious global threat. In the journal Angewandte Chemie, a Chinese research team has now introduced a method for the development of novel antibiotics to fight resistant pathogens. The drugs are based on p more
The intricacies of how intestinal bacteria adapt to their environment have yet to be fully explored. Researchers from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of California, Berkeley, USA, have now successfully closed a gap in this knowledge: The more
A paper-based platform developed by researchers at the Indian Institute of Science (IISc) and Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) could help quickly detect the presence of antibiotic-resistant, disease-causing bacteria. One of mankind's greatest challenges has been the more
Antibiotic resistance Antibiotic resistance is the ability of a microorganism to withstand the effects of an antibiotic . It is a specific type of drug resistance . Antibiotic resistance evolves naturally via natural selection through random mu ... more
Watchlist
This is where you can add this topic to your personal favourites
© 1997-2024 LUMITOS AG, All rights reserved
